Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01568320 · ClinicalTrials.gov registry record · NA
Zenith® Dissection Clinical Trial
A NA study, sponsored by Cook Research Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 73
- Enrollment target
NCT01568320 is a NA study that has completed, run by Cook Research Incorporated. The registered enrollment target is 73 participants.
The verdict
NCT01568320, a NA study, has completed, sponsored by Cook Research Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 73 participants
- Enrollment target
Study Summary
The Zenith® Dissection Clinical Trial is a clinical trial approved by US FDA to study the safety and effectiveness of the Zenith® Dissection Endovascular System in the treatment of acute, complicate Type B aortic dissection.
Interventions
- DEVICE Endovascular Treatment (Zenith)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2012-08 |
| Est. Completion | 2020-01-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01568320
The ClinicalTrials.gov registry entry for NCT01568320 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cook Research Incorporated, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Endovascular Treatment (Zenith) is the first listed.
NCT01568320 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01568320 about?
NCT01568320 is a clinical study titled "Zenith® Dissection Clinical Trial". The Zenith® Dissection Clinical Trial is a clinical trial approved by US FDA to study the safety and effectiveness of the Zenith® Dissection Endovascular System in the treatment of acute, complicate Type B aortic dissection.
What is the current status of trial NCT01568320?
This trial is currently completed. It is a NA study. The enrollment target is 73 participants. The study started on 2012-08. Estimated completion is 2020-01-27.
What interventions are being tested in trial NCT01568320?
The interventions under investigation include: Endovascular Treatment (Zenith) (DEVICE).
Who is sponsoring clinical trial NCT01568320?
This trial is sponsored by Cook Research Incorporated, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.